Pegaspargase
From Infogalactic: the planetary knowledge core
| Systematic (IUPAC) name | |
|---|---|
|
Pegylated E. coli L-asparagine amidohydrolase
|
|
| Clinical data | |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a695031 |
| Pregnancy category |
|
| Legal status |
|
| Identifiers | |
| CAS Number | 130167-69-0  |
| ATC code | L01XX24 (WHO) |
| DrugBank | DB00059 |
| UNII | 7D96IR0PPM |
| Chemical data | |
| Formula | C1377H2208N382O442S17 |
| Molecular mass | 31731.9 g/mol |
| (verify) | |
Pegaspargase /pəˈɡæspərɡeɪz/, trade name Oncaspar, is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase[1] which has undergone PEGylation.
It is used in the treatment of acute lymphoblastic leukemia.[2][3]
See also
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.[dead link]
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Articles with dead external links from October 2010
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Articles without KEGG source
- Articles without InChI source
- Antineoplastic drugs
- Antineoplastic and immunomodulating drug stubs
